U2H-32479-50961
3 vaccinations
5 coded responses
18 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 941 / CA
- Registered
- 2022-07-13
- Relationship
- Child or adolescent in my care
- Guardian
- C4M-12894-19163
- Race
- White
- Ethnicity
- N/A
Timeline
-
2022-07-07
Dose 1 — Moderna
-
2022-07-13
Registered in v-safe
- 2022-07-13
- 2022-07-16
- 2022-07-21
- 2022-07-28
- 2022-08-04
-
2022-08-08
Dose 2 — Moderna
- 2022-08-11
- 2022-08-12
-
2022-08-13
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Nasal congestion — Feeling: FairFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-08-14
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Cough, Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Nasal congestion, mild cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-15
Survey response — day 7, dose 2, dependentMedDRA: Cough, Nasal congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Nasal congestion; mild coughMedDRA releases: 2024-11 · check-in free text available
- 2022-08-22
- 2022-08-29
- 2022-09-05
- 2022-09-12
- 2022-09-19
-
2022-11-07
Survey response — 3 months, dose 2, dependentMedDRA: COVID-19, Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Congestion, runny nose, cough, COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-07
Dose 3 — Pfizer-BioNTechCo-administered: Tetanus
-
2023-02-06
Survey response — 6 months, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: GoodMedDRA releases: 2024-11
- 2023-06-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-07 | Moderna | No |
| 2 | 2022-08-08 | Moderna | No |
| 3 | 2022-12-07 | Pfizer-BioNTech | Tetanus |
Free text
Release 12 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Nasal congestion
Systemic reaction (other): Nasal congestion, mild cough, runny nose
Release 12 — day 7, dose 2, dependent
Systemic reaction (other): Nasal congestion; mild cough
Release 12 — 3 months, dose 2, dependent
Symptoms: Congestion, runny nose, cough, COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release